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Objective: Surgical aortic valvuloplasty is increasingly employed in the management
of children and adolescents with aortic regurgitation, but the durability of this ap-
proach and factors associated with outcome are not well defined.
Methods: From 1989 to 2005, a total of 81 patients younger than 19 years with mod-
erate or severe aortic regurgitation underwent surgical aortic valvuloplasty. Aortic re-
gurgitation was congenital in 20 cases, after treatment of aortic stenosis in 30, from
other injuries to the aortic valve in 12, and from other causes in 19. Eighteen patients
had moderate or severe aortic stenosis. Preoperative left ventricular end-diastolic
dimension z score was 4.9 6 2.7.
Results: After surgical aortic valvuloplasty with various techniques, including peri-
cardial leaflet augmentation in 80%, aortic regurgitation was improved in 77 patients
and was mild or less in 68. Ten of 18 patients with moderate or severe aortic stenosis
before repair had a decrease to mild, whereas 2 had progression from mild to moder-
ate. Left ventricular end-diastolic dimension z score decreased by 2.9 6 2.1 (P ,
.001). During follow-up (median 4.7 years), 33 patients underwent aortic valve rein-
terventions, including aortic valve replacement in 25. Estimated freedoms from aortic
valve replacement were 72% 6 6% at 5 years and 54% 6 9% at 7.5 years and were
shorter in patients with moderate or severe aortic stenosis before surgical aortic val-
vuloplasty. Among surviving patients who did not undergo aortic valve replacement,
aortic regurgitation at follow-up was moderate in 21 and trivial or mild in 34; left
ventricular and aortic root dimensions were preserved.
Conclusion: Surgical aortic valvuloplasty is a valid option with good intermediate re-
sults for children and adolescents with aortic regurgitation from a variety of causes,
particularly for patients with less than moderate aortic stenosis.
S
everal surgical options are available for the treatment of aortic regurgitation
(AR) in young patients, including various techniques of aortic valve repair,
or surgical aortic valvuloplasty (SAVP), and aortic valve replacement
(AVR) with mechanical,1,2 bioprosthetic,3,4 or autologous pulmonary5,6 valves.
SAVP may have particularly important advantages in children relative to the alterna-
tives, including freedom from the risks of a small mechanical prosthesis, avoidance of
anticoagulation, and avoidance of the drawbacks of an autograft AVR, such as aortic
root dilation and need for a right ventricle–pulmonary artery conduit. The apparent
advantages of SAVP in young patients depend, however, on low morbidity and dura-
ble aortic valve function after repair. To date, few reports of SAVP in children, most
with small numbers of patients and limited follow-up, have been published.7-14 The
purpose of this study was to analyze results of SAVP in a large number of children
and young patients with AR and to explore factors associated with improved outcome.
Earn CME credits at http://
cme.ctsnetjournals.org
From the Departments of Cardiac Surgerya
and Cardiology,b Children’s Hospital Bos-
ton and Harvard Medical School, Boston,
Mass; the Division of Pediatric Cardiotho-
racic Surgery, University of Texas South-
western Medical Center and Children’s
Medical Center, Dallas, Texc; and the Divi-
sion of Cardiovascular Surgery, Children’s
National Medical Center, Washington, DC.d
EAB reports grant support from CryoLife
Inc, Kennesaw, Ga.
*Both authors contributed equally to the
authorship of this article.
Received for publication July 17, 2007;
revisions received Sept 11, 2007; accepted
for publication Sept 26, 2007.
Address for reprints: Doff B. McElhinney,
MD, Department of Cardiology, Children’s
Hospital, Boston, MA 02115 (E-mail: doff.
mcelhinney@cardio.chboston.org).
J Thorac Cardiovasc Surg 2008;135:552-9
0022-5223/$34.00
Copyright  2008 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.09.057552 The Journal of Thoracic and Cardiovascular Surgery c March 2008
Bacha et al Surgery for Congenital Heart Disease
CH
DAbbreviations and Acronyms
AR 5 aortic regurgitation
AS 5 aortic stenosis
AVR 5 aortic valve replacement
LV 5 left ventricular
LVEDD 5 left ventricular end-diastolic dimension
LVFS 5 fractional shortening
SAVP 5 surgical aortic valvuloplasty
Materials and Methods
This protocol was approved by the Children’s Hospital Commit-
tee on Clinical Investigation.
Patients
The Cardiovascular Program database at Children’s Hospital (Bos-
ton, Mass) was queried for children and adolescents (,19 years)
who underwent SAVP for AR with or without associated valvular
aortic stenosis (AS) from 1989 to 2005. Only patients who under-
went repair of the aortic valve were included. Patients who had
only a root reduction or annular plication without alteration of the
valve leaflets were excluded. Other exclusion criteria included the
following: a univentricular circulation, a morphologically right ven-
tricle functioning as the systemic ventricle, and other associated
causes of left ventricular (LV) volume overload, such as a ventricular
septal defect or significant mitral regurgitation. Patients with an an-
atomic pulmonary or truncal valve in the aortic position were in-
cluded if they did not meet other exclusion criteria. The decision
to undertake surgery was based on the judgment of the treating phy-
sicians and not necessarily on strict anatomic or functional criteria.
Cross-sectional follow-up was obtained by April 2007.
Classification of AR
The causes of AR were classified as follows: (1) congenital, (2) re-
sulting from transcatheter or surgical treatment of congenital valvu-
lar AS, (3) caused by trauma during other cardiac interventions, (4)
caused by endocarditis or rheumatic heart disease, (5) related to ab-
normal truncal valve, and (6) resulting from dilation or distortion of
the neoaortic root or an abnormal neoaortic (native pulmonary)
valve after arterial switch operation.
Echocardiographic Measurements
Aortic valve function and dimensions. ARwas graded echocar-
diographically according to a composite assessment scale as none or
trivial, mild (no LV dilation, no retrograde flow in the descending
aorta, ARvena contractawidth,4mm),moderate (LV end-diastolic
volume or LV end-diastolic dimension [LVEDD] z score .2 and
,4, retrograde flow in the descending aorta, vena contracta 4–6
mm), or severe (LV end-diastolic volume or LVEDD z score .4,
retrograde flow in the descending aorta, vena contracta .6 mm).
Valvular AS was estimated by Doppler evaluation from multiple
views, and the highest maximum instantaneous gradient was re-
corded. AS was categorized as moderate or greater (gradient .50
mm Hg) or less than moderate (#50 mm Hg). Aortic valve annulus
and root diameters were measured from parasternal long-axis im-
ages, with the root diameter taken as the maximum dimension atThe Journal of Thorthe level of the sinuses. These measurements were indexed to
body surface area and reported as z scores.
Ventricular dimensions and function. LV dimensions, vol-
umes, mass, and fractional shortening (LVFS) were measured and
calculated from apical four-chamber and cross-sectional echocar-
diographic images,15 indexed to body surface area, and reported
as z scores. Short-axis LVEDD and LV end-systolic dimension
were measured. In some studies, LV end-diastolic volume and LV
end-systolic volume were also calculated. Because LV volumes
were assessed adequately at the desired time points for fewer pa-
tients than were LV linear dimensions, however, only LVEDD
and LV end-systolic dimension z scores were used for analysis.
Aortic Valvuloplasty
A variety of aortic valvuloplasty techniques were used, with multi-
ple techniques often used in a single patient. Most of these, or var-
iations thereof, have been described previously.7-13 These were
categorized as pericardial augmentation or extension of leaflets, cre-
ation of a leaflet, repair of a torn or perforated leaflet, reattachment or
resuspension of a dehisced or prolapsing leaflet, and commissuro-
plasty. Pericardial augmentation or extension consisted of a variety
of techniques, including augmentation of prolapsing or deficient
leaflets, use of a pericardial patch to close a rudimentary commissure
or combine a rudimentary leaflet with a larger leaflet, and extension
of leaflets, usually after excision of thickened or malformed edges.
Autologous pericardium was fixed in 0.6% glutaraldehyde for 5 to
10 minutes. Creation of a leaflet was used to replace absent or se-
verely deficient leaflet tissue that was resected; it involved fashion-
ing a patch of autologous pericardium into a leaflet, which was then
sutured to the aortic root. Closure of perforated or torn leaflets in-
volved either direct suture closure or closure with a pericardial
patch. Reattachment or resuspension of leaflets involved reattach-
ment of dehisced leaflets, resuspension of prolapsing leaflets, or re-
attachment of leaflets deliberately separated from the aortic wall to
resect a rudimentary leaflet and plicate a dilated aortic root (mostly
in patients with truncus arteriosus). Commissuroplasty involved re-
pair or tightening of commissures with mattress sutures placed from
outside the aorta to inside the lumen. Patients with coexisting AS of-
ten underwent commissurotomy along with the listed valvuloplasty
techniques. Thinning of leaflets was frequently performed in con-
junction with these techniques and was not specified separately.
Intraoperative transesophageal echocardiography was typically
used, particularly during the latter part of our experience, to assess
the repair and guide revision if necessary. In our more recent expe-
rience, preoperative and intraoperative 3-dimensional echocardiog-
raphy was frequently used to define the anatomy of the regurgitant
valve and to assess the repair (Figure 1).
Data Analysis
The primary outcome was freedom from AVR after SAVP. Second-
ary outcomes included acute and chronic changes in AR and left
heart dimensions and function, severity of AS, freedom from any
aortic valve reintervention, and survival. Independent variables an-
alyzed for association with outcomes included age; etiology, sever-
ity, and time course of AR; associated anomalies and interventions;
preoperative AS; preoperative left heart dimensions and function;
type of SAVP; and early postoperative AR. Time-dependent out-
comes were assessed with Kaplan—Meier analysis and multivari-
able Cox regression analysis. For comparison of continuous oracic and Cardiovascular Surgery c Volume 135, Number 3 553
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DFigure 1. Matrix array 3-dimensional echocardio-
graphic images of aortic valve in patient with
severe congenital atrial regurgitation before
(Pre) and after (Post) surgical aortic valvuloplasty.
Image before surgical aortic valvuloplasty (top)
demonstrates partial left-right leaflet fusion, large
central deficiency in fused left-right leaflet, and
thickening of all leaflets. Image after surgical aor-
tic valvuloplasty (bottom) demonstrates three
well-formed leaflets that coapt nicely. There
was no aortic regurgitation after surgical aortic
valvuloplasty. R, Right leaflet; L, left leaflet; N,
noncoronary leaflet.categoric variables between groups, independent samples t test and
c2 analyses, respectively, were used. For comparison of preopera-
tive and postoperative data within patients, paired t test analysis
was used. Multivariable analysis of discrete outcomes was per-
formed with multiple logistic regression. Correlation between con-
tinuous variables was assessed with linear regression. Data are
presented as mean 6 SD or median with range.
Results
Patients
From 1989 to 2005, a total of 81 patients met the inclusion cri-
teria for this study and underwent SAVP at amedian age of 8.6
years (1month–18.4years). Twenty-oneof these patientswere
reported on previously.7 Twenty-three patients (28%)were in-
fants and children younger than 5 years, 29 (36%) were chil-
dren between 5 and 11 years old, and 29 (36%) were
adolescents (.11 and ,19 years). Sixty-two patients (77%)
had associated cardiovascular anomalies, and 57 (70%) had
undergone at least one previous intervention (Table E1).
Severity and Causes of AR
Preoperative AR was severe in 52 patients (64%) and moder-
ate in 29 (36%). The distribution of different etiologies of AR
is summarized in Table 1. Among patients with congenital554 The Journal of Thoracic and Cardiovascular Surgery c MaAR, 1 had a quadrileaflet aortic valve with partial deficiency
of multiple leaflets, 3 had a completely absent right coronary
leaflet, 5 had a tricommissural valve with deficiency of 1 or
more leaflets (usually the right or noncoronary leaflets), 1
had a unicommissural valve and central deficiency, and the
remaining patients had a bicommissural valve with central
deficiency. In all but 1 of these patients, the AR emanated
from the area of the right or noncoronary cusp.
Among patients with only moderate AR, indications for
surgery included concomitant moderate or severe AS in 11,
additional surgical procedures in 8, young age in 4, endocardi-
tis in 2, traumatic AR with difficulty weaning from ventilator
support in the early postoperative period in 1, and other in 3.
Among patients with AR caused by intervention for con-
genital AS, the most recent AS procedure was a median of 3.6
years (10 days–14 years) before SAVP. Among patients with
AR resulting from other types of valve injury, the procedure
causing valve damage was a median of 3.5 years (1 day–9
years) before SAVP.
Preoperative AS
Moderate or greater AS was present in 18 patients (22%): 15
with AR after previous treatment of AS (P , .001 vs otherrch 2008
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DTABLE 1. Types and causes of aortic regurgitation
Type or cause No. %
Congenital 20 25
After previous treatment of aortic stenosis* 30 37
Balloon aortic valvuloplasty 28 35
Surgical aortic valvotomy 4 5
Other traumatic or iatrogenic cause 12 15
Leaflet perforation during subaortic stenosis resection 3 4
Leaflet perforation during modified Konno procedure 2 2
Other leaflet perforation (VSD closure, Rastelli operation, or atrioventricular canal defect repair) 3 4
Leaflet tethering from VSD closure during ASO 2 2
Leaflet or commissure tethering from repair of aortopulmonary window with tetralogy of Fallot 1 1
Leaflet partially avulsed during transcatheter closure of multiple muscular VSDs 1 1
Truncus arteriosus, abnormal truncal valve 9 11
Transposition of the great arteries with root distortion or abnormal neoaortic valve after ASO 5 6
Rheumatic fever or endocarditis 5 6
VSD, Ventricular septal defect; ASO, arterial switch operation. *A total of 40 previous balloon dilation or surgical aortic valvotomy procedures were performed
in 30 patients, with multiple procedures in 9 patients (2 procedures in 8 and 3 procedures in 1).causes), 2 with congenital AR, and 1 with truncus arteriosus.
Patients with moderate or greater pre-SAVP AS were more
likely to have moderate AR than severe AR (11 of 29 with
moderate AR vs 7 of 52 with severe AR, P 5 .01) and had
lower z scores for both aortic annulus diameter (1.1 6 1.6
vs 3.9 6 3.2, P 5 .001) and LVEDD (2.9 6 2.1 vs 5.5 6
2.5, P , .001) than patients without significant AS.
LV Dimensions and Function
LV dimensions and function at baseline are summarized in
Table E2. Pre-SAVP LV dilation was less severe in younger
(,5 years) patients than in older patients (LVEDD z score 3.7
6 1.2 vs 5.3 6 2.9, P 5 .02), in patients with moderate AR
than in those with severe AR (LVEDD z score 5.8 6 2.4 vs
2.9 6 2.1, P , .001), in and patients with at least moderate
AS than in those with mild or no AS (LVEDD z score 2.9
6 2.1 vs 5.56 2.5, P, .001). Seven patients, all with mod-
erate AR, had a normal pre-SAVP LVEDD z score (,2); 5
had moderate or greater AS and 2 had AR caused by aortic
valve injury during surgery for other anomalies.
Aortic Valvuloplasty
Surgical procedures on the aortic valve are summarized in
Table 2. In 80% of patients, including 28 of 30 with AR after
treatment of AS, leaflets were augmented or extended with
pericardium, often in conjunction with other techniques. Ad-
ditional procedures were performed in 25 patients (Table 3).
Outcomes
Survival. Cross-sectional follow-up was obtained for all
but 1 patient (3%) a median of 4.5 years (1 month–16 years)
after SAVP. There were 3 deaths. Estimated survivals
according to Kaplan–Meier analysis were 97% 6 2% at 1
year and 96% 6 2% at 5 years. The first death was that ofThe Journal of Thoa 14-year-old with congenital AR and LV dysfunction who
had a cardiac arrest as a result of an aortic dissection 2
days after SAVP. This patient died despite AVR. The second
patient died during AVR, 2 years after SAVP, as the result of
a platelet transfusion reaction. The third death was that of an
infant with an atrioventricular canal defect, multiple muscu-
lar ventricular septal defects, and a prosthetic mitral valve
who underwent SAVP for traumatic AR and died suddenly
at home 1 year after SAVP of unknown causes.
Postoperative AR. Early after SAVP (1–26 days), AR
was improved in 77 patients (95%): by 1 grade in 19 patients,
by 2 grades in 46, and by 3 or 4 grades in 12. ARwas trivial or
none in 22 patients (27%), mild in 46 (57%), moderate in 13
(16%), and severe in none. None of the variables analyzed
were associated with worse postoperative AR.
At most recent follow-up of the 78 surviving patients (be-
fore AVR if applicable), the degree of AR was severe in 11
patients, moderate in 32, and trivial or mild in 35. Among
the 55 surviving patients that did not undergo AVR, a median
of 4.2 years after repair (1 month–12 years), the degree of AR
was moderate in 21 and trivial or mild in 34.
Follow-up aortic root diameter z scores, including mea-
surements before surgery for patients who underwent AVR,
did not differ from pre-SAVP z scores (P5 .45). One patient
who underwent AVR had endocarditis diagnosed 4.4 years
after SAVP.
Postoperative AS. Among 18 patients with at least moder-
ate AS before SAVP, 10 (56%) had a decrease to mild or less
in the early post-SAVP period and 8 continued to have mod-
erate AS. There was a trend toward lower aortic annulus
z scores among the 8 patients whose AS did not improve
(median z score 0.8 vs 2.2, P 5 .11). Two patients with
less than moderate AS before SAVP had an increase to
moderate AS in the early post-SAVP period. According toracic and Cardiovascular Surgery c Volume 135, Number 3 555
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DTABLE 2. Techniques of aortic valve repair and additional surgical procedures
Procedures No. %
Aortic valve repair procedures*
Pericardial augmentation of leaflet(s) 65 80
Commissuroplasty 30 37
Repair of perforated or torn leaflet(s) 18 22
Resuspension or reattachment of dehisced, avulsed, or prolapsing leaflet 12 15
Creation of a leaflet 6 7
Additional surgical procedures
Patients 25 31
Procedures
Aortic root reduction or aneurysmorrhaphy 5 6
Subaortic stenosis resection or modified Konno procedure 6 7
Replacement of a pulmonary outflow conduit 6 7
Augmentation of ascending aorta for supravalvular aortic stenosis 5 6
Mitral valvuloplasty for mitral stenosis or mild mitral regurgitation 3 3
Reoperative mitral valve replacement 2 2
Other 2 2
*Multiple aortic valve repair procedures were performed in 47 patients (57%), so the number of procedures listed does not total 81.multivariable logistic regression, the only factor associated
with moderate or greater postoperative AS was moderate or
greater preoperative AS (P , .001).
Eight patients with less than moderate AS both before
SAVP and early after SAVP had a diagnosis of moderate
or greater AS a median of 3 years (0.5–6 years) after
SAVP. Two of these patients had peak Doppler gradients
early after SAVP of 45 mm Hg, just below the threshold
for moderate AS. In all 8 cases, the SAVP included pericar-
dial augmentation or extension of aortic valve leaflets; in 6,
SAVP was originally performed for AR resulting from treat-
ment of congenital AS.
Postoperative LV dimensions and function. On early
postoperative echocardiography (n 5 66), the LVEDD z
score was lower than the preoperative z score in all but 4 pa-
tients (P, .001). The average postoperative LVEDD z score
of 2.16 2.6 was 2.96 2.0 lower than the pre-SAVP z score
(P , .001; Figure 2). Among patients with a pre-SAVP
LVEDD z score greater than 4 (n5 45), the LVEDD z score
decreased in all but 1; overall, the decrease in LVEDD z score
in these patients was greater than in those with less severe
dilation (decrease by 3.8 6 1.8 vs 1.5 6 1.7, P , .001).
At most recent follow-up of patients who did not undergo
AVR, the post-SAVP decrease in LVEDD was preserved (z
score 1.7 6 2.4), whereas among those who underwent
AVR, the pre-AVR LVEDD z score was 4.2 6 2.7. LVFS z
score atmost recent follow-up among patientswho did not un-
dergo AVR was 1.76 2.2; among patients who did undergo
AVR, the pre-AVR LVFS z score was20.26 2.6. In only 2
patientswas the LVFS z score below the normal range (,22);
both underwent AVR.
Aortic valve reintervention. During a median follow-up
of 4.7 years (1 month–17 years), 33 patients underwent 1556 The Journal of Thoracic and Cardiovascular Surgery c Maor more reinterventions on the aortic valve: repeated SAVP
in 3 cases, balloon aortic valvuloplasty in 8, and AVR in
25. This includes 3 patients who underwent early postopera-
tive reintervention—for revision of the valvuloplasty in 2
cases and AVR in 1—because of dehiscence of a created or
augmented leaflet. Freedoms from aortic valve reintervention
were 91%6 3% at 1 year, 63%6 6% at 5 years, and 41%6
8% at 7.5 years. Factors associated with shorter freedom from
aortic valve reintervention according to multivariable Cox re-
gression were the presence of moderate or greater AS at the
time of SAVP (5-year freedom from reintervention 33% 6
13% vs 70% 6 7%, P , .001; Figure 3) and larger pre-
SAVP LVEDD z score (P 5 .05). None of the other factors
analyzed were associated with freedom from AVR. Notably,
freedom from reintervention did not differ according to age at
SAVP, type or cause of AR, technique of SAVP, or moderate
AR early after SAVP.
AVRwith a mechanical valve prosthesis (n5 20), pulmo-
nary autograft (n 5 4), or aortic allograft (n 5 1) was per-
formed in 25 patients a median of 3.7 years (2 days–9
years) after SAVP, at a median age of 13.5 years (10
months–26 years). At the time of AVR, the degree of AR
was severe in 11 patients, moderate in 10, and mild in 4,
and 11 had at least moderate AS. One of the patients who un-
derwent pulmonary autograft AVR had endocarditis. In pa-
tients whose SAVP included pericardial augmentation or
recreation of leaflets, the pericardium was often found at
the time of AVR to be highly calcified and immobile, which
presumably contributed to the ultimate failure of the repair.
Among the 4 patients with mild AR, 2 hadmoderate or severe
AS and LV dysfunction, 1 underwent early post-SAVP AVR
after an aortic dissection and cardiac arrest, and 1 underwent
AVR at the time of reoperation for the primary indication ofrch 2008
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Da progressive aortic root aneurysm. Freedoms from AVR af-
ter SAVP were 95% 6 3% at 1 year, 72% 6 6% at 5 years,
and 54% 6 9% at 7.5 years. The only factor associated with
shorter freedom from AVRwas moderate or greater AS at the
time of SAVP (74% 6 7% vs 60% 6 14% at 5 years, P 5
.05; Figure E1). None of the other factors analyzed were as-
sociated with time to AVR, including age; among children 11
years old or younger at the time of SAVP, freedoms from
AVRwere 77%6 7% at 5 years and 59%6 10% at 7.5 years
(P 5 .3 vs patients .11 years old).
A second SAVP for recurrent AR was performed in 3 pa-
tients: in the early postoperative period in 2 patients and 3.4
Figure 3. Kaplan-Meier graph demonstrating freedoms from any
aortic valve reintervention and from aortic valve replacement
(AVR) after surgical aortic valvuloplasty in entire cohort.
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Figure 2. Line graph demonstrating change in left ventricular (LV)
short-axis end-diastolic dimension (EDD) z score from before sur-
gical aortic valvuloplasty (Pre-SAVP) to early (<1 month) after
surgical aortic valvuloplasty (Post-SAVP) for each patient.The Journal of Thoyears after SAVP in a patient with truncus arteriosus and
a dysplastic aortic valve, whose AR decreased frommoderate
to mild after repeat SAVP and was unchanged 4.8 years later.
Eight patients (6 with congenital AS and 2 with congenital
AR and AS) underwent balloon aortic valve dilatation for AS
a median of 5.4 years (0.4–8.3 years) after SAVP, which had
included pericardial aortic valve augmentation in 7 patients.
Angiographically, the augmented leaflets appeared calcified
and immobile in these 7 patients. Balloon dilatation was suc-
cessful in all cases, reducing the peak AS gradient from a me-
dian of 80mmHg (55–110mmHg) to 40mmHg (20–60mm
Hg) without increasing AR to more than mild. An additional
balloon dilatation procedure was performed in 3 patients (9–
30 months later), with similarly successful results. Three pa-
tients (none of whom had a repeated balloon dilatation) sub-
sequently underwent AVR, all within 11 months of balloon
dilatation, either for recurrent severe AS (n5 1) or for resid-
ual or recurrent moderate AS with LV dysfunction (n 5 2).
The 5 patients who did not undergo AVR were followed
up for 3.9 to 10 years after SAVP and 0.1 to 3.6 years after
the most recent balloon valvuloplasty procedure.
Discussion
Acute Benefits of SAVP in Children and
Adolescents with AR
In our experience, SAVP was effective at acutely reducing
AR and improving LV dilation in children and adolescents
with AR from a variety of causes. Other investigators have
reported similarly promising early outcomes after SAVP in
children and adolescents with congenital heart disease, al-
though most series are relatively small, include patients
with primarily AS, or include simple as well as complex re-
pairs.7-14 Nevertheless, the growing body of literature on this
topic suggests that SAVP is effective at decreasing AR in the
short term and, as we have shown in this study, allows rapid
reverse LV remodeling even in patients with severe LV dila-
tion.
Intermediate Outcomes After SAVP in Children and
Adolescents with AR
In this series of children and adolescents with moderate or se-
vere AR who underwent SAVP, freedoms from any aortic
valve reintervention at 5 and 7.5 years were 63% 6 6%
and 41% 6 8%, respectively, and freedoms from AVR at 5
and 7.5 years were 72% 6 6% and 54% 6 9%. Our experi-
ence includes many young children, and the durability of re-
pair was just as good in these patients as in older children and
adolescents. With regard to intermediate-term aortic valve
function, the literature is mixed. Other published studies
have demonstrated progressively decreasing freedom from
aortic valve reintervention during the several years after
SAVP, although the frequency and time course of reinterven-
tion vary.9,11,12,14 This series was intended to focus on com-
plex repairs in patients with significant AR and did notracic and Cardiovascular Surgery c Volume 135, Number 3 557
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Dinclude patients with isolated AS, less than moderate AR, or
ventricular septal defect–associated AR, for whom the usual
techniques of repair have proved durable.12,16
Despite the limited follow-up data on SAVP in children
with congenital heart disease and complex AR, more abun-
dant literature concerning the use of pericardial leaflet exten-
sion in both children and adults with rheumatic AR and in
adults with AR and a structurally normal aortic valve demon-
strates that repairs incorporating pericardial augmentation of
leaflets can function well for many years.17-20 The optimal
approaches to certain technical elements of pericardial leaflet
augmentation are not well defined, particularly the duration
of pericardial fixation. In patients undergoing AVR after
SAVP in our series, the pericardial patches were often
heavily calcified and contracted, presumably contributing
to progressive post-SAVP aortic valve dysfunction. Our cur-
rent practice is to fix the pericardium in glutaraldehyde for 5
to 10 minutes, shorter than in our early experience, which
leaves the pericardium more pliable; however, the effect of
this modification has yet to be determined.
In patients without significant AR after SAVP, LV dimen-
sions and function improved after SAVP and remained stable
at follow-up, regardless of pre-SAVP LV size. This is in con-
trast to the findings of Tafreshi and colleagues,22 who ob-
served that a preoperative LVEDD z score greater than 4
was associated with worse functional outcome and persistent
LV dilation after AVR in children and adolescents with
AR.21
Postoperative AS After SAVP in Children and
Adolescents with AR
One of the potential adverse outcomes of SAVP for AR in pa-
tients with congenitally abnormal valves is postoperative AS.
This is a particular concern in patients who have AR develop
after balloon dilatation for AS. In our experience, 22% of pa-
tients had moderate or greater AS in addition to AR before
SAVP, and more than half of these had a reduction in AS
to mild or less after SAVP, probably in part as a result of re-
ductions in LV volume load and forward stroke volume. Pa-
tients with moderate or greater AS had lower aortic annulus z
scores than did those with mild or less AS, and there was
a trend toward lower aortic annulus z scores among patients
whose AS did not improve.
New or increased AS after SAVP was uncommon. Even
when significant AS was not present early after SAVP, how-
ever, it sometimes developed with time. The cause of this
progressive AS was not clear, but all affected patients under-
went SAVP with pericardium to repair the aortic valve, and
pericardial calcification or contraction may have been a con-
tributing factor, as discussed previously.
A unique feature of this series was the subset of 8 patients
who underwent balloon aortic valvuloplasty for AS after
SAVP. Most of these patients had AR after previous balloon
valvuloplasty for congenital AS, and all had significant AS at558 The Journal of Thoracic and Cardiovascular Surgery c Mathe time of SAVP. In all cases, balloon dilatation decreased
AS in the acute term. Although 3 of the 8 patients ultimately
underwent AVR, the other 5 were alive without AVR as long
as 10 years after SAVP. There was no significant increase in
AR after balloon dilatation in any of these patients. Accord-
ingly, balloon aortic valvuloplasty may be an effective and
safe first-line treatment for patients with AS but minimal
AR after SAVP.
Management of AR in Children and Adolescents
Although published reports present guidelines for manage-
ment of AR in young patients,22 the optimal timing and
method of intervention for AR in children remain challeng-
ing, and there are limited data to help guide the choice be-
tween SAVP and AVR in this patient population. Because
serious adverse outcomes were uncommon, our data do not
allow inferences that might provide firmer guidance regard-
ing timing and method of intervention in children and adoles-
cents with AR. Of note, age at the time of SAVP was
associated neither with worse short- or long-term outcome
nor with the duration of freedom from reintervention. Our re-
sults do support several important conclusions: there are few
short- to intermediate-term drawbacks of SAVP, LV dimen-
sions typically normalize or improve substantially after
SAVP even when severe dilation is present, and SAVP
allows substantial delay of AVR for most patients, which
may facilitate eventual AVR with a larger prosthesis or bio-
prosthesis. With improved patient selection and surgical
techniques, the durability of SAVP should continue to
improve.
A common alternative to SAVP in children and adoles-
cents with aortic valve disease is the Ross procedure.4-6,23
In contrast to SAVP, the Ross procedure involves replace-
ment of the entire aortic root, with reimplantation of the cor-
onary arteries, as well as placement of a valved conduit
between the right ventricle and pulmonary arteries. Apart
from an important incidence of need for conduit replacement,
there is increasing evidence of significant progressive neo-
aortic root dilation and autograft failure.5,23
Limitations
This study is limited by its retrospective nature, by the hetero-
geneous patient population, and by the fact that referral for
surgery was subjective in most cases. Furthermore, this expe-
rience encompasses a period when the techniques of SAVP
were under development and thus may include a learning
curve. Regular serial measurements of post-SAVP LV geom-
etry and function were not available, which limits our insight
into the evolution of changes in aortic valve function and LV
size and function with time. Although the relative benefits
and drawbacks of SAVP relative to therapeutic alternatives,
such as mechanical or pulmonary autograft AVR, would be
useful, this study does not allow direct comparison between
SAVP and AVR.rch 2008
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DConclusions
This study demonstrates that SAVP is a valid option with
good intermediate results for children and adolescents with
AR from a variety of causes, particularly those with less
than moderate AS. We now consider primary SAVP for es-
sentially every patient with AR, aside from those with asso-
ciated greater then moderate AS or a small aortic annulus, for
whom a Ross or Ross–Konno procedure may be preferred.
References
1. Karamlou T, Jang K, Williams WG, Caldarone CA, Van Arsdell G,
Coles JG, et al. Outcomes and associated risk factors for aortic valve re-
placement in 160 children: a competing-risks analysis. Circulation.
2005;112:3462-9.
2. Alexiou C, McDonald A, Langley SM, Dalrymple-Hay MJ, Haw MP,
Monro JL. Aortic valve replacement in children: are mechanical prosthe-
ses a good option? Eur J Cardiothorac Surg. 2000;17:125-33.
3. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of
aortic valve allografts in young recipients. J Thorac Cardiovasc Surg.
1993;105:934-41.
4. Lupinetti FM, Duncan BW, Lewin M, Dyamenahalli U, Rosenthal GL.
Comparison of autograft and allograft aortic valve replacement in chil-
dren. J Thorac Cardiovasc Surg. 2003;126:240-6.
5. Laudito A, Brook MM, Suleman S, Bleiweis MS, Thompson LD,
Hanley FL, et al. The Ross procedure in children and young adults:
a word of caution. J Thorac Cardiovasc Surg. 2001;122:147-53.
6. Elkins RC, LaneMM,McCue C. Ross operation in children: late results.
J Heart Valve Dis. 2001;10:736-41.
7. Bacha EA, Satou GM, Moran AM, Zurakowski D, Marx GR, Keane JF,
et al. Valve-sparing operation for balloon-induced aortic regurgitation in
congenital aortic stenosis. J Thorac Cardiovasc Surg. 2001;122:162-8.
8. Caspi J, Ilbawi MN, Roberson DA, Piccione W, Monson DO, Najafi H.
Extended aortic valvuloplasty for recurrent valvular stenosis and regur-
gitation in children. J Thorac Cardiovasc Surg. 1994;107:1114-20.
9. Hasaniya N, Gundry SR, Razzouk AJ, Mulla N, Bailey LL. Outcome of
aortic valve repair in children with congenital aortic valve insufficiency.
J Thorac Cardiovasc Surg. 2004;127:970-4.
10. Hawkins JA, Minich LL, Shaddy RE, Tani LY, Orsmond GS,
Sturtevant JE, et al. Aortic valve repair and replacement after balloon
aortic valvuloplasty in children. Ann Thorac Surg. 1996;61:1355-8.
11. Odim J, Laks H, Allada V, Child J, Wilson S, Gjertson D. Results of aor-
tic valve-sparing and restoration with autologous pericardial leaflet ex-
tensions in congenital heart disease. Ann Thorac Surg. 2005;80:647-53.
12. Tweddell JS, Pelech AN, Frommelt PC, Jaquiss RD, Hoffman GM,
Mussatto KA, et al. Complex aortic valve repair as a durable and effec-
tive alternative to valve replacement in children with aortic valve dis-
ease. J Thorac Cardiovasc Surg. 2005;129:551-8.The Journal of Thor13. Alsoufi B, Karamlou T, Bradley T, Williams WG, Van Arsdell GS,
Coles JG, et al. Short and midterm results of aortic valve cusp extension
in the treatment of children with congenital aortic valve disease. Ann
Thorac Surg. 2006;82:1292-9.
14. Hawkins JA, Kouretas PC, Holubkov R, Williams RV, Tani LY, Su JT,
et al. Intermediate-term results of repair for aortic, neoaortic, and truncal
valve insufficiency in children. J Thorac Cardiovasc Surg. 2007;133:
1311-7.
15. Colan SD, McElhinney DB, Crawford EC, Keane JF, Lock JE. Valida-
tion and re-evaluation of a discriminant model predicting anatomic suit-
ability for biventricular repair in neonates with aortic stenosis. J Am Coll
Cardiol. 2006;47:1858-65.
16. Trusler GA, Williams WG, Smallhorn JF, Freedom RM. Late results af-
ter repair of aortic insufficiency associated with ventricular septal defect.
J Thorac Cardiovasc Surg. 1992;103:276-81.
17. Bozbuga N, Erentug V, Kirali K, Akinci E, Isik O, Yakut C. Midterm
results of aortic valve repair with the pericardial cusp extension tech-
nique in rheumatic valve disease. Ann Thorac Surg. 2004;77:1272-6.
18. Al Halees Z, Al Shahid M, Al Sanei A, Sallehuddin A, Duran C. Up to
16 years follow-up of aortic valve reconstruction with pericardium:
a stentless readily available cheap valve? Eur J Cardiothorac Surg.
2005;28:200-5.
19. Kumar N, Gometza B, al Halees Z, Duran C. Surgery for aortic regurgi-
tation in the young: repair versus replacement. J Cardiovasc Surg
(Torino). 1992;33:7-13.
20. Kalangos A, Beghetti M, Baldovinos A, Vala D, Bichel T, Mermillod B,
et al. Aortic valve repair by cusp extension with the use of fresh autolo-
gous pericardium in children with rheumatic aortic insufficiency.
J Thorac Cardiovasc Surg. 1999;118:225-36.
21. Tafreshi RI, Shahmohammadi A, Davari PN. Predictors of left ventric-
ular performance after valve replacement in children and adolescents
with chronic aortic regurgitation. Pediatr Cardiol. 2005;26:331-7.
22. American College of Cardiology; American Heart Association Task
Force on Practice Guidelines (Writing Committee to revise the 1998
guidelines for the management of patients with valvular heart disease);
Society of Cardiovascular Anesthesiologists, Bonow RO,
Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the
management of patients with valvular heart disease: a report of the
American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (writing Committee to Revise the 1998
guidelines for the management of patients with valvular heart disease)
developed in collaboration with the Society of Cardiovascular Anesthe-
siologists endorsed by the Society for Cardiovascular Angiography and
Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol.
2006;48:e1-148.
23. Pasquali SK, CohenMS, Shera D, Wernovsky G, Spray TL, Marino BS.
The relationship between neo-aortic root dilation, insufficiency, and
reintervention following the Ross procedure in infants, children, and
young adults. J Am Coll Cardiol. 2007;49:1806-12.acic and Cardiovascular Surgery c Volume 135, Number 3 559
Surgery for Congenital Heart Disease Bacha et al
CH
DFigure E1. Kaplan–Meier graphs demonstrating freedom from aor-
tic valve replacement (AVR) among patients with moderate or
greater aortic stenosis (AS) before surgical aortic valvuloplasty
and those with less than moderate aortic stenosis. Numbers of
patients at risk at 0, 1, 3, 5, 7, 9, and 11 years are listed.559.e1 The Journal of Thoracic and Cardiovascular Surgery c March 2008
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DTABLE E1. Associated cardiovascular anomalies and previous interventions
Anomalies and interventions No. %
Associated anomalies 62 77
Valvular AS 35 43
Subvalvular AS 11 14
Supravalvular AS 4 5
Coarctation of the aorta 5 6
Mitral stenosis 2 2
Transposition of the great arteries or double-outlet right ventricle 10 12
Truncus arteriosus 9 11
Ventricular septal defect or atrioventricular canal defect 5 6
Tetralogy of Fallot with aortopulmonary window 1 1
Previous interventions 57 70
Previous surgical interventions 35 43
Truncus arteriosus repair 9 11
Arterial switch operation 9 11
After previous pulmonary artery band 4 5
Subaortic stenosis resection or modified Konno procedure 5 6
Surgical aortic valvotomy for AS 4 5
Repair of atrioventricular canal defect 3 3
Coarctation repair 3 3
Mitral valve replacement 2 2
Other 3 3
Previous catheter interventions 32 40
Balloon aortic valve dilatation 28 35
Coarctation dilatation or stenting 3 3
Ventricular septal defect closure 2 2
Pulmonary outflow conduit dilatation 1 1
AS, Aortic stenosis.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 3 559.e2
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DTABLE E2. Baseline left ventricular and aortic dimensions and functional parameters
Parameter Mean 6 SD Range
LV fractional shortening (%) 37% 6 7% 25%–55%
LV fractional shortening z score 0.5 6 2.1 23.7–5.2
LV end-diastolic diameter z score 4.9 6 2.7 21.5–12.7
LV end-systolic diameter z score 3.0 6 2.6 23.1–8.5
LV mass z score (n 5 67) 3.9 6 1.9 20.4–8.6
Aortic valve annulus diameter z score 3.2 6 3.2 22.9–13.2
Aortic root diameter z score 3.3 6 3.2 20.6–15.7
Adequate data were available for 75 patients unless otherwise specified. LV, left ventricular.559.e3 The Journal of Thoracic and Cardiovascular Surgery c March 2008
